Getinge/Castle, Inc. Names New Vice President
John Aymong Joins Management Team
ROCHESTER, NY-John Aymong has been named Senior Vice President of Manufacturing Operations at Getinge/Castle, Inc. With 29 years of manufacturing experience with companies including General Electric Company, STERIS Corporation, and Copes-Vulcan Inc., Aymong has been a plant manager, general manager, and vice president of manufacturing. During his career, Aymong helped implement of a Total Quality Management Process that resulted in ISO 9001 Certification for operations and lead negotiations of three labor contracts with the UAW. Getinge/Castle President and CEO, Creighton A. White, remarked, "John has dedicated his career to progressively leading manufacturing operations, developing and improving systems, and pioneering efficient production areas. We welcome his expertise and know-how as we continue to build our business in the healthcare and scientific marketplace."
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
